Title of article :
3-(Indol-2-yl)indazoles as Chek1 kinase inhibitors: Optimization of potency and selectivity via substitution at C6
Author/Authors :
Mark E. Fraley، نويسنده , , Justin T. Steen، نويسنده , , Edward J. Brnardic، نويسنده , , Kenneth L. Arrington، نويسنده , , Keith L. Spencer، نويسنده , , Barbara A. Hanney، نويسنده , , Yuntae Kim، نويسنده , , George D. Hartman، نويسنده , , Steven M. Stirdivant، نويسنده , , Bob A. Drakas، نويسنده , , Keith Rickert، نويسنده , , Eileen S. Walsh، نويسنده , , Kelly Hamilton، نويسنده , , Carolyn A. Buser، نويسنده , , James Hardwick، نويسنده , , Weikang Tao، نويسنده , , Stephen C. Beck، نويسنده , , Xianzhi Mao، نويسنده , , Robert B. Lobell، نويسنده , , Laura Sepp-Lorenzino، نويسنده , , et al.، نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 2006
Pages :
5
From page :
6049
To page :
6053
Abstract :
The development of 3-(indol-2-yl)indazoles as inhibitors of Chek1 kinase is described. Introduction of amides and heteroaryl groups at the C6 position of the indazole ring system provided sufficient Chek1 potency and selectivity over Cdk7 to permit escape from DNA damage-induced arrest in a cellular assay. Enzyme potency against Chek1 was optimized by the incorporation of a hydroxymethyl triazole moiety in compound 21 (Chek1 IC50 = 0.30 nM) that was shown by X-ray crystallography to displace one of three highly conserved water molecules in the HI region of the ATP-binding cleft.
Keywords :
Chek1 kinase , DNA damage , CDK7 kinase , Oncology , indazoles , indoles , Checkpoint escape
Journal title :
Bioorganic & Medicinal Chemistry Letters
Serial Year :
2006
Journal title :
Bioorganic & Medicinal Chemistry Letters
Record number :
797525
Link To Document :
بازگشت